top of page

Same-day shipping before 2 PM EST ✦ Janoshik-verified COA ✦ Free shipping over $200 ✦

Durham Peptides Canadian peptide supplier logo

Same-day shipping before 2 PM EST ✦ Janoshik-verified COA ✦ Free shipping over $200 ✦

Buy Tirzepatide in Canada: The Complete Dual Agonist Research Peptide Buyer's Guide

  • Writer: Durham Peptides
    Durham Peptides
  • 2 days ago
  • 6 min read
Buy tirzepatide peptide Canada dual agonist research Durham Peptides

Buy tirzepatide peptide Canada dual agonist research Durham Peptides


Tirzepatide represents the second generation of incretin peptide research — the first dual-agonist compound to activate both GLP-1 and GIP receptors simultaneously. For Canadian researchers studying metabolic peptide pharmacology, tirzepatide sits at the intersection of single-agonist semaglutide (older generation) and triple-agonist retatrutide (newer generation), making it a central reference compound for incretin research.


This guide covers the tirzepatide purchase decision: what to evaluate in a supplier, how dual-agonism affects research considerations, vial size and pricing, and how tirzepatide fits in a complete metabolic research peptide catalog.


For the scientific overview of tirzepatide as a research compound, see What Is Tirzepatide? The Dual Agonist Peptide Advancing Metabolic Research. For the classification question that frequently comes up, see Is Tirzepatide a Peptide?. For the comparison with semaglutide, see Semaglutide vs Tirzepatide: The Canadian Research Peptide Comparison.


A Quick Refresher on Tirzepatide


Tirzepatide is a synthetic 39-amino-acid peptide that activates two incretin receptors simultaneously: GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide). The dual-receptor mechanism is what distinguishes it from single-agonist compounds like semaglutide.


Key structural features:


  • 39-amino-acid backbone (versus 31 for semaglutide)

  • Modeled on the natural GIP sequence with engineered modifications

  • Fatty acid conjugation for extended half-life

  • Balanced dual-receptor activity


Is Tirzepatide Available in Canada?


Yes. Durham Peptides' Tirzepatide 10mg is supplied as a lyophilized vial with Janoshik-verified purity, shipped same-day from Ontario as a research peptide for laboratory use only.


The pharmaceutical brand-name versions of tirzepatide (Mounjaro, Zepbound) are separate products under prescription regulation and are not the same as research peptide tirzepatide.


What to Look For When Buying Tirzepatide in Canada


The standard six-criteria framework applies:


1. Independent third-party testing with verifiable Janoshik COA. Every tirzepatide vial should include a Janoshik COA with a unique verification key. See How to Verify a Janoshik Test Report Unique Key and How to Read a Janoshik COA.


2. ≥99% HPLC purity with mass spectrometry identity. Mass spec should confirm tirzepatide molecular weight (~4,813 g/mol). For complex 39-amino-acid peptides with multiple modifications, identity verification is particularly important.


3. Synthetic SPPS manufacturing. Tirzepatide should be manufactured via Solid-Phase Peptide Synthesis with no animal-derived materials. See Vegan Peptides.


4. Lyophilized in sealed glass vial. White/off-white lyophilized powder in sealed glass vial with tamper-evident seal.


5. Domestic Canadian shipping. Same-day dispatch from Canadian supplier. See How Durham Peptides Ships Research Peptides Across Canada.


6. Transparent Canadian pricing. Pricing in CAD without hidden fees.


Tirzepatide Pricing in Canada


Janoshik-tested research-grade tirzepatide 10mg vials in Canada generally range from $60-$130 CAD. The price reflects the complexity of synthesizing a 39-amino-acid peptide with dual-agonist receptor activity — more complex than 31-amino-acid semaglutide, less complex than triple-agonist retatrutide.


Current Durham Peptides tirzepatide pricing is on the Tirzepatide 10mg product page in Canadian dollars. Free shipping on orders over $200 CAD. Bulk pricing available — contact info@durhampeptides.ca.


Tirzepatide vs Semaglutide vs Retatrutide: Where Tirzepatide Fits


Tirzepatide is the second generation of incretin peptides:


  • 1st generation (single agonist): Semaglutide — GLP-1 only, 31 amino acids

  • 2nd generation (dual agonist): Tirzepatide — GLP-1 + GIP, 39 amino acids

  • 3rd generation (triple agonist): Retatrutide — GLP-1 + GIP + glucagon, ~39 amino acids



When Tirzepatide Is the Right Research Choice


Choose tirzepatide for research when:


  • The research investigates dual GLP-1 + GIP receptor pharmacology

  • Comparative research positions dual-agonism between single and triple agonist mechanisms

  • The research follows established tirzepatide protocols

  • Mid-tier pricing fits the research budget (between semaglutide and retatrutide)


For single-receptor research, semaglutide is the cleaner reference compound. For triple-receptor research, retatrutide is the reference.


Tirzepatide Reconstitution


Tirzepatide is supplied as lyophilized powder requiring bacteriostatic water for reconstitution.


Common reconstitution: 2mL bacteriostatic water for 10mg vial = 5 mg/mL = 50 mcg per unit on a 100-unit insulin syringe.



Tirzepatide Storage


Standard research peptide storage:

  • Lyophilized: 2-8°C or -20°C. 12-24 months shelf life.

  • Reconstituted: 2-8°C only. 28-day shelf life.


Regulatory Context


Research peptide tirzepatide and brand-name pharmaceutical tirzepatide (Mounjaro, Zepbound) are governed by separate regulatory frameworks:


  • Research peptide: Laboratory use only, not approved for therapeutic use

  • Pharmaceutical: FDA-approved with specific therapeutic indications, prescription-required


Tirzepatide research peptide is not part of the FDA's July 2026 PCAC review (which covers peptides like BPC-157, MOTS-c, TB-500). For broader regulatory context, see FDA Peptide Reclassification 2026.


Why Durham Peptides for Tirzepatide


Every Durham Peptides tirzepatide vial includes:

  • Janoshik Analytical third-party testing with unique verification key

  • ≥99% HPLC purity confirmation

  • Mass spectrometry identity confirming tirzepatide molecular weight

  • 100% synthetic vegan manufacturing (SPPS)

  • Same-day dispatch from Ontario on orders before 2:00 PM EST

  • Canada Post Xpresspost shipping with tracking

  • Free shipping on orders over $200 CAD

  • Transparent Canadian-dollar pricing


Frequently Asked Questions


Can I buy tirzepatide in Canada? Yes. Durham Peptides stocks tirzepatide 10mg for research use, shipped same-day from Ontario.


How much does tirzepatide cost in Canada? Current Durham Peptides pricing is on the product page. Canadian market range is $60-$130 CAD per 10mg vial.


Is tirzepatide Health Canada approved? Research peptide tirzepatide is sold for laboratory use only and is not approved for therapeutic use. The pharmaceutical brand-name versions (Mounjaro, Zepbound) are separately regulated medications.


Is tirzepatide a peptide? Yes. Tirzepatide is a synthetic 39-amino-acid peptide. See Is Tirzepatide a Peptide?.


Is tirzepatide the same as Mounjaro? Tirzepatide is the active ingredient in Mounjaro and Zepbound. Research peptide tirzepatide and brand-name pharmaceutical tirzepatide contain the same molecule but operate under separate regulatory frameworks.


What vial size does Durham Peptides sell tirzepatide in? 10mg lyophilized powder in a sealed glass vial.


How does tirzepatide compare to semaglutide? Tirzepatide is a dual GLP-1 + GIP agonist (39 amino acids). Semaglutide is a single GLP-1 agonist (31 amino acids). See Semaglutide vs Tirzepatide.


How does tirzepatide compare to retatrutide? Tirzepatide is a dual agonist. Retatrutide is a triple agonist (adds glucagon receptor). See Retatrutide vs Tirzepatide vs Semaglutide.


Why is tirzepatide more expensive than semaglutide? Tirzepatide's longer 39-amino-acid sequence and dual-receptor design require more complex synthesis than semaglutide's 31-amino-acid single-agonist structure.


What do I need to reconstitute tirzepatide? Bacteriostatic water, syringe, alcohol wipes. See How to Reconstitute Peptides.


How do I verify my tirzepatide is genuine? Janoshik COA with unique verification key, plus mass spectrometry identity confirmation. See How to Read a Janoshik COA.


Can I buy tirzepatide in bulk? Yes. Contact info@durhampeptides.ca.


Does Durham Peptides ship tirzepatide internationally? Within Canada only.

Is Durham Peptides' tirzepatide vegan? Yes. SPPS-manufactured with no animal-derived materials.


What's the molecular weight of tirzepatide? Approximately 4,813 g/mol. The Janoshik mass spectrometry should confirm this on every batch.


Final Thoughts


Tirzepatide is the central reference compound in second-generation incretin peptide research — between single-agonist semaglutide and triple-agonist retatrutide. For Canadian researchers studying dual GLP-1 + GIP receptor pharmacology, tirzepatide is the established research peptide choice.


Buying tirzepatide in Canada follows the same fundamental criteria as any research peptide: Janoshik-verified third-party testing with unique keys, ≥99% HPLC purity with mass spec identity, synthetic SPPS manufacturing, Canadian domestic shipping, and transparent pricing.


Durham Peptides' Tirzepatide 10mg meets all six criteria, Janoshik-verified, SPPS-manufactured, shipped same-day from Ontario. For researchers building a complete incretin research catalog, see Buy Semaglutide in Canada and Buy Retatrutide in Canada.

Browse our complete metabolic research peptide catalog at durhampeptides.ca.


Selected Research References


  1. Frias JP, Davies MJ, Rosenstock J, et al. Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine. 2021;385(6):503-515. https://pubmed.ncbi.nlm.nih.gov/34170647/

  2. Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine. 2022;387(3):205-216. https://pubmed.ncbi.nlm.nih.gov/35658024/

  3. Coskun T, Sloop KW, Loghin C, et al. LY3298176, a Novel Dual GIP and GLP-1 Receptor Agonist for the Treatment of Type 2 Diabetes Mellitus. Molecular Metabolism. 2018;18:3-14. https://pubmed.ncbi.nlm.nih.gov/30473097/

  4. Willard FS, Douros JD, Gabe MBN, et al. Tirzepatide is an Imbalanced and Biased Dual GIP and GLP-1 Receptor Agonist. JCI Insight. 2020;5(17):e140532. https://pubmed.ncbi.nlm.nih.gov/32730231/

  5. Min T, Bain SC. The Role of Tirzepatide, Dual GIP and GLP-1 Receptor Agonist, in the Management of Type 2 Diabetes: The SURPASS Clinical Trials. Diabetes Therapy. 2021;12(1):143-157. https://pubmed.ncbi.nlm.nih.gov/33325008/


All products sold by Durham Peptides are for research and laboratory use only. They are not intended for human or animal consumption, diagnosis, treatment, cure, or prevention of any disease.

bottom of page